Little Green Pharma has revealed plans to demerge its psychedelics business into a separate unlisted entity, while forming a research partnership with Curtin University.
Perth companies Emerald Clinics and Little Green Pharma are seeking to raise up to $18 million ahead of stock market listings as they pursue very different strategies in the medicinal cannabis market.
